InsiderClue
Insiders · Profile

Kauffman Michael

Director at Verastem · Director at Adicet Bio · Director at Karyopharm Therapeutics. Filing since 17 Jun 2014. CIK 0001364719

VSTM Verastem, Inc. Director · 5 trades ACET Adicet Bio, Inc. Director · 1 trade KPTI Karyopharm Therapeutics Inc. Director · 75 trades
Company
Date
Role
Action
Shares
Amount
Of holding
VSTM Verastem, Inc.
21 Nov 2025
Director
Sold on a plan
8,550
$85.50K
49.7%
ACET Adicet Bio, Inc.
5 Jun 2024
Director
Sold at will
5,900
$8.44K
50.0%
KPTI Karyopharm Therapeutics Inc.
28 Feb 2022
Director
Sold, plan not stated
6,226
$63.74K
0.7%
KPTI Karyopharm Therapeutics Inc.
28 Feb 2022
Director
Sold, plan not stated
6,226
$63.74K
0.9%
KPTI Karyopharm Therapeutics Inc.
17 Feb 2022
Director
Sold, plan not stated
9,088
$110.18K
1.0%
KPTI Karyopharm Therapeutics Inc.
17 Feb 2022
Director
Sold, plan not stated
9,079
$110.07K
1.3%
KPTI Karyopharm Therapeutics Inc.
7 Feb 2022
Director
Sold, plan not stated
6,764
$66.71K
0.9%
KPTI Karyopharm Therapeutics Inc.
7 Feb 2022
Director
Sold, plan not stated
6,707
$66.14K
0.7%
KPTI Karyopharm Therapeutics Inc.
18 Mar 2021
Chief Executive Officer
Sold, plan not stated
4,000
$49.55K
0.6%
KPTI Karyopharm Therapeutics Inc.
18 Feb 2021
Chief Executive Officer
Sold, plan not stated
9,495
$140.82K
1.2%
KPTI Karyopharm Therapeutics Inc.
18 Feb 2021
Chief Executive Officer
Sold, plan not stated
9,495
$140.82K
1.6%
KPTI Karyopharm Therapeutics Inc.
11 Feb 2021
Chief Executive Officer
Sold, plan not stated
6,642
$103.08K
0.9%
KPTI Karyopharm Therapeutics Inc.
11 Feb 2021
Chief Executive Officer
Sold, plan not stated
6,601
$102.44K
1.2%
KPTI Karyopharm Therapeutics Inc.
12 Oct 2020
Chief Executive Officer
Sold, plan not stated
7,500
$111.68K
1.0%
KPTI Karyopharm Therapeutics Inc.
17 Aug 2020
Chief Executive Officer
Sold, plan not stated
1,477
$22.16K
0.2%
KPTI Karyopharm Therapeutics Inc.
15 Jul 2020
Chief Executive Officer
Sold, plan not stated
7,500
$145.72K
1.0%
KPTI Karyopharm Therapeutics Inc.
10 Jul 2020
Chief Executive Officer
Sold, plan not stated
7,500
$142.54K
1.3%
KPTI Karyopharm Therapeutics Inc.
9 Jul 2020
Chief Executive Officer
Sold, plan not stated
7,500
$146.49K
1.0%
KPTI Karyopharm Therapeutics Inc.
22 Jun 2020
Chief Executive Officer
Sold, plan not stated
7,500
$150.00K
1.0%
KPTI Karyopharm Therapeutics Inc.
15 Jun 2020
Chief Executive Officer
Sold, plan not stated
7,500
$122.78K
1.0%
KPTI Karyopharm Therapeutics Inc.
10 Jun 2020
Chief Executive Officer
Sold, plan not stated
7,500
$135.94K
1.3%
KPTI Karyopharm Therapeutics Inc.
9 Jun 2020
Chief Executive Officer
Sold, plan not stated
7,500
$138.75K
1.0%
KPTI Karyopharm Therapeutics Inc.
18 May 2020
Chief Executive Officer
Sold, plan not stated
7,500
$150.00K
1.0%
KPTI Karyopharm Therapeutics Inc.
15 May 2020
Chief Executive Officer
Sold, plan not stated
7,500
$139.84K
1.0%
KPTI Karyopharm Therapeutics Inc.
7 May 2020
Chief Executive Officer
Sold, plan not stated
7,500
$147.21K
1.3%
KPTI Karyopharm Therapeutics Inc.
7 May 2020
Chief Executive Officer
Sold, plan not stated
7,500
$147.20K
1.0%
KPTI Karyopharm Therapeutics Inc.
9 Apr 2020
Chief Executive Officer
Sold, plan not stated
10,000
$206.40K
1.8%
KPTI Karyopharm Therapeutics Inc.
8 Apr 2020
Chief Executive Officer
Sold, plan not stated
10,000
$186.12K
1.3%
KPTI Karyopharm Therapeutics Inc.
10 Mar 2020
Chief Executive Officer
Sold, plan not stated
10,000
$222.19K
1.8%
KPTI Karyopharm Therapeutics Inc.
9 Mar 2020
Chief Executive Officer
Sold, plan not stated
10,000
$225.19K
1.3%
KPTI Karyopharm Therapeutics Inc.
19 Feb 2020
Chief Executive Officer
Sold, plan not stated
8,817
$145.32K
1.2%
KPTI Karyopharm Therapeutics Inc.
19 Feb 2020
Chief Executive Officer
Sold, plan not stated
8,817
$145.32K
1.6%
KPTI Karyopharm Therapeutics Inc.
11 Feb 2020
Chief Executive Officer
Sold, plan not stated
10,000
$174.29K
1.8%
KPTI Karyopharm Therapeutics Inc.
10 Feb 2020
Chief Executive Officer
Sold, plan not stated
10,000
$169.33K
1.3%
KPTI Karyopharm Therapeutics Inc.
9 Jan 2020
Chief Executive Officer
Sold, plan not stated
10,000
$191.88K
1.8%
KPTI Karyopharm Therapeutics Inc.
8 Jan 2020
Chief Executive Officer
Sold, plan not stated
10,000
$185.71K
1.3%
KPTI Karyopharm Therapeutics Inc.
10 Dec 2019
Chief Executive Officer
Sold, plan not stated
10,000
$159.90K
1.9%
KPTI Karyopharm Therapeutics Inc.
9 Dec 2019
Chief Executive Officer
Sold, plan not stated
10,000
$170.21K
1.3%
KPTI Karyopharm Therapeutics Inc.
11 Nov 2019
Chief Executive Officer
Sold, plan not stated
10,000
$147.61K
1.9%
KPTI Karyopharm Therapeutics Inc.
8 Nov 2019
Chief Executive Officer
Sold, plan not stated
10,000
$146.25K
1.3%
KPTI Karyopharm Therapeutics Inc.
1 Nov 2019
Chief Executive Officer
Sold, plan not stated
10,000
$120.00K
1.3%
KPTI Karyopharm Therapeutics Inc.
1 Nov 2019
Chief Executive Officer
Sold, plan not stated
10,000
$120.00K
1.9%
KPTI Karyopharm Therapeutics Inc.
16 Sep 2019
Chief Executive Officer
Sold, plan not stated
10,000
$120.00K
1.3%
KPTI Karyopharm Therapeutics Inc.
16 Sep 2019
Chief Executive Officer
Sold, plan not stated
10,000
$120.00K
1.9%
KPTI Karyopharm Therapeutics Inc.
7 Jan 2019
Chief Executive Officer
Sold, plan not stated
12,500
$127.82K
1.7%
KPTI Karyopharm Therapeutics Inc.
7 Dec 2018
Chief Executive Officer
Sold, plan not stated
12,500
$126.42K
1.7%
KPTI Karyopharm Therapeutics Inc.
26 Nov 2018
Chief Executive Officer
Sold, plan not stated
9,600
$105.60K
1.8%
KPTI Karyopharm Therapeutics Inc.
19 Nov 2018
Chief Executive Officer
Sold, plan not stated
400
$4.45K
0.1%
KPTI Karyopharm Therapeutics Inc.
7 Nov 2018
Chief Executive Officer
Sold, plan not stated
12,500
$145.59K
1.7%
KPTI Karyopharm Therapeutics Inc.
18 Oct 2018
Chief Executive Officer
Sold, plan not stated
10,000
$126.30K
1.9%
KPTI Karyopharm Therapeutics Inc.
8 Oct 2018
Chief Executive Officer
Sold, plan not stated
12,500
$196.83K
1.7%
VSTM Verastem, Inc.
28 Sep 2018
Director
Bought
4,000
$29.96K
opened
KPTI Karyopharm Therapeutics Inc.
18 Sep 2018
Chief Executive Officer
Sold, plan not stated
10,000
$182.62K
1.9%
KPTI Karyopharm Therapeutics Inc.
7 Sep 2018
Chief Executive Officer
Sold, plan not stated
12,500
$241.38K
1.7%
KPTI Karyopharm Therapeutics Inc.
20 Aug 2018
Chief Executive Officer
Sold, plan not stated
10,000
$174.57K
1.9%
KPTI Karyopharm Therapeutics Inc.
7 Aug 2018
Chief Executive Officer
Sold, plan not stated
12,500
$225.56K
1.7%
KPTI Karyopharm Therapeutics Inc.
18 Jul 2018
Chief Executive Officer
Sold, plan not stated
10,000
$182.69K
1.9%
KPTI Karyopharm Therapeutics Inc.
9 Jul 2018
Chief Executive Officer
Sold, plan not stated
12,500
$233.99K
1.7%
KPTI Karyopharm Therapeutics Inc.
18 Jun 2018
Chief Executive Officer
Sold, plan not stated
10,000
$186.56K
1.9%
KPTI Karyopharm Therapeutics Inc.
7 Jun 2018
Chief Executive Officer
Sold, plan not stated
10,000
$172.99K
1.4%
KPTI Karyopharm Therapeutics Inc.
18 May 2018
Chief Executive Officer
Sold, plan not stated
10,000
$193.87K
1.9%
KPTI Karyopharm Therapeutics Inc.
7 May 2018
Chief Executive Officer
Sold, plan not stated
10,000
$167.75K
1.4%
KPTI Karyopharm Therapeutics Inc.
18 Apr 2018
Chief Executive Officer
Sold, plan not stated
10,000
$147.88K
1.9%
KPTI Karyopharm Therapeutics Inc.
9 Apr 2018
Chief Executive Officer
Sold, plan not stated
10,000
$124.83K
1.4%
KPTI Karyopharm Therapeutics Inc.
19 Mar 2018
Chief Executive Officer
Sold, plan not stated
10,000
$152.90K
1.9%
KPTI Karyopharm Therapeutics Inc.
7 Mar 2018
Chief Executive Officer
Sold, plan not stated
10,000
$161.46K
1.4%
KPTI Karyopharm Therapeutics Inc.
20 Feb 2018
Chief Executive Officer
Sold, plan not stated
10,000
$147.87K
1.9%
KPTI Karyopharm Therapeutics Inc.
7 Feb 2018
Chief Executive Officer
Sold, plan not stated
10,000
$125.05K
1.4%
KPTI Karyopharm Therapeutics Inc.
18 Jan 2018
Chief Executive Officer
Sold, plan not stated
10,000
$100.88K
1.9%
KPTI Karyopharm Therapeutics Inc.
8 Jan 2018
Chief Executive Officer
Sold, plan not stated
10,000
$100.77K
1.4%
KPTI Karyopharm Therapeutics Inc.
18 Dec 2017
Chief Executive Officer
Sold, plan not stated
10,000
$91.55K
1.9%
KPTI Karyopharm Therapeutics Inc.
7 Dec 2017
Chief Executive Officer
Sold, plan not stated
10,000
$103.90K
1.4%
VSTM Verastem, Inc.
24 Aug 2015
Director
Sold, plan not stated
2,070
$13.37K
100%
VSTM Verastem, Inc.
19 Mar 2015
Director
Sold, plan not stated
930
$10.19K
31.0%
KPTI Karyopharm Therapeutics Inc.
12 Jan 2015
Chief Executive Officer
Sold, plan not stated
25,000
$825.00K
3.2%
KPTI Karyopharm Therapeutics Inc.
12 Jan 2015
Chief Executive Officer
Sold, plan not stated
25,000
$825.00K
4.3%
VSTM Verastem, Inc.
17 Sep 2014
Director
Bought
3,000
$27.30K
opened
KPTI Karyopharm Therapeutics Inc.
2 Jul 2014
Chief Executive Officer
Sold, plan not stated
100,000
$4.25M
11.0%
KPTI Karyopharm Therapeutics Inc.
2 Jul 2014
Chief Executive Officer
Sold, plan not stated
100,000
$4.25M
14.5%
KPTI Karyopharm Therapeutics Inc.
18 Jun 2014
Chief Executive Officer
Sold, plan not stated
10,000
$431.52K
1.4%
KPTI Karyopharm Therapeutics Inc.
17 Jun 2014
Chief Executive Officer
Sold, plan not stated
10,000
$403.64K
1.1%
81 decisions on file.